Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Human Vaccines & Immunotherapeutics

• Publication date

  2015-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4161/hv.34419PMID 25181315PMCID PMC4514222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence of Community-Acquired Lower Respiratory Tract Infections and Pneumonia among Older Adults in the United Kingdom: A Population-Based Study

  2013cited by this paper
• The Changing Microbiologic Epidemiology of Community-Acquired Pneumonia

  2013cited by this paper
• Risk factors for community-acquired pneumonia in adults in Europe: a literature review

  2013cited by this paper
• Empirical antibiotic therapy (ABT) of lower respiratory tract infections (LRTI) in the elderly: application of artificial neural network (ANN). Preliminary results.

  2012cited by this paper
• Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia

  2012cited by this paper
• Alcohol drinking and risk of subsequent hospitalisation with pneumonia

  2011cited by this paper
• Impact of influenza during the post-pandemic season: epidemiological picture from syndromic and virological surveillance.

  2011cited by this paper
• Investigation on seasonal influenza vaccination among children with high-risk medical conditions who live in the area of Local Health Agency 4 "Chiavarese".

  2011cited by this paper
• Risk of pneumonia in patients taking statins: population-based nested case-control study.

  2011cited by this paper
• Clinical and economic burden of community-acquired pneumonia among adults in Europe

  2010cited by this paper
• Determinants of community-acquired pneumonia in children and young adults in primary care

  2010cited by this paper
• Acid-suppressive Drugs and Community-acquired Pneumonia

  2009cited by this paper
• Syndrome surveillance and molecular epidemiology for early detection and tracing of an outbreak of measles in Liguria, Italy

  2009cited by this paper
• New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality

  2009cited by this paper
• Risk of community‐acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population‐based case–control study

  2009cited by this paper
• Epidemiology of community-acquired pneumonia in older adults: a population-based study.

  2009cited by this paper
• Identification of new risk factors for pneumonia: population-based case-control study.

  2009cited by this paper
• Diabetes, Glycemic Control, and Risk of Hospitalization With Pneumonia

  2008cited by this paper
• Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults.

  2008cited by this paper
• The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 Study

  2008cited by this paper
• New evidence of risk factors for community-acquired pneumonia: a population-based study

  2008cited by this paper
• Emergency department syndromic surveillance system for early detection of 5 syndromes: a pilot project in a reference teaching hospital in Genoa, Italy.

  2008cited by this paper
• Increasing Hospital Admissions for Pneumonia, England

  2008cited by this paper
• Type 2 Diabetes and Pneumonia Outcomes: A population-based cohort study

  2008cited by this paper
• EPIVAC Study Group. Epidemiology of community-acquired pneumonia in older adults: A population-based study

  2008cited by this paper
• Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

  2007cited by this paper
• Statins and the Risk of Pneumonia: A Population‐Based, Nested Case‐Control Study

  2007cited by this paper
• Risk factors for community-acquired pneumonia in German adults: the impact of children in the household

  2007influential reference
• The current burden of pneumococcal disease in England and Wales.

  2006cited by this paper
• The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens.

  2006cited by this paper
• Statin treatment and reduced risk of pneumonia in patients with diabetes

  2006influential reference
• Community-acquired pneumonia in Europe: causative pathogens and resistance patterns

  2002cited by this paper
• Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community

  2001cited by this paper
• Hospital Admissions for Pneumonia in Spain

  2001cited by this paper
• role of serum troponin levels combined with electrocardiographic findings Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

  2001cited by this paper
• Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults

  2000cited by this paper
• Community-acquired pneumonia

  1998cited by this paper
• Incidence of Community-Acquired Pneumonia Requiring Hospitalization Results of a Population-Based Active Surveillance Study in Ohio

  1997cited by this paper
• Community-acquired pneumonia.

  1995cited by this paper

• The current definition, epidemiology, animal models and a novel therapeutic strategy for aspiration pneumonia.

  2021cites this paper
• Lowering the recommended age for the free and active offer of influenza vaccination in Italy: clinical and economic impact analysis in the Liguria region

  2020cites this paper
• Hospital and economic burden of influenza-like illness and lower respiratory tract infection in adults ≥50 years-old

  2019cites this paper
• [Results of the First Mexican Consensus of Vaccination in the Adult].

  2017cites this paper
• The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis.

  2017cites this paper
• Resultados del Primer Consenso Mexicano de Vacunación en el Adulto

  2017cites this paper
• Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid)

  2016cites this paper
• Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy

  2016cites this paper
• Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination

  2016cites this paper
• Update on the pathogenesis and management of pneumonia in the elderly-roles of aspiration pneumonia.

  2015cites this paper
• Methodological criticisms in the evaluation of Pneumococcal Conjugate Vaccine effectiveness

  2015influential citation